Aptagen

Loganville, United States Founded: 2004 • Age: 22 yrs
Aptamers and synthetic antibodies are developed for research applications.

About Aptagen

Aptagen is a company based in Loganville (United States) founded in 2004.. Aptagen offers products and services including Apta-Index, Custom Oligos, Custom Peptides, and R&D Contract Service. Aptagen operates in a competitive market with competitors including Aptamer Group, Aptamer Sciences, Base Pair Biotechnologies, Femtogenix and Apta Biotech, among others.

  • Headquarter Loganville, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Aptagen, Llc
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $83.09 K (USD), Grant

    Sep 12, 2008

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Aptagen

Aptagen offers a comprehensive portfolio of products and services, including Apta-Index, Custom Oligos, Custom Peptides, and R&D Contract Service. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Database for aptamer information and research applications.

Tailored DNA sequences for biotechnology and research needs.

Specialized peptides for therapeutic and diagnostic purposes.

Contract-based R&D for aptamer development and projects.

People of Aptagen
Headcount 1-10
Employee Profiles 5
Employee Profiles
People
Derek Koch
Chem Lab Manager
People
G. Thomas Caltagirone
President & CEO
People
Michelle L. Young
Administrative Assistant
People
Albert M. Liao
Lab Director

Unlock access to complete

Funding Insights of Aptagen

  • Total Funding
  • Total Rounds 1
  • Last Round Grant — $83,094
  • First Round

    (12 Sep 2008)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2008 Amount Grant - Aptagen Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Aptagen

Aptagen has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Military Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Administers health care and support for military personnel and operations.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Aptagen

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Aptagen

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Aptagen Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Aptagen

Aptagen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aptamer Group, Aptamer Sciences, Base Pair Biotechnologies, Femtogenix and Apta Biotech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Manufacturer of DNA and RNA nucleic acid aptamers for use in research & development
domain founded_year HQ Location
Proprietary aptamer technology is utilized for protein analysis.
domain founded_year HQ Location
Services for custom aptamer development
domain founded_year HQ Location
DNA-interactive payload molecules for ADCs are developed by Femtogenix.
domain founded_year HQ Location
Aptamers are developed and provided via SELEX platform technology.
domain founded_year HQ Location
Aptamer-based biotechnological applications are developed for diverse uses.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Aptagen

Frequently Asked Questions about Aptagen

When was Aptagen founded?

Aptagen was founded in 2004 and raised its 1st funding round 4 years after it was founded.

Where is Aptagen located?

Aptagen is headquartered in Loganville, United States. It is registered at Loganville, Georgia, United States.

What does Aptagen do?

Aptagen, a biotechnology company, was founded in 2004 and is located in Loganville, United States. Aptamer products and services are provided as research reagents, diagnostics, and therapeutics. The portfolio includes aptamers as synthetic antibodies, Apta-Beacon for analyte detection, Peptimers combining apta-peptides, and next-generation aptamers. Operations focus on biotechnology applications in research and development.

Who are the top competitors of Aptagen?

Aptagen's top competitors include Aptamer Group, Aptamer Sciences and Base Pair Biotechnologies.

What products or services does Aptagen offer?

Aptagen offers Apta-Index, Custom Oligos, Custom Peptides, and R&D Contract Service.

Who are Aptagen's investors?

Aptagen has 1 investor. Key investors include Military Health.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available